Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

Translated title of the contribution: Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

J.M. Hoebert, A.K. Mantel-Teeuwisse, L. van Dijk, J.W.J. Bijlsma, H.G.M. Leufkens

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionDo rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries
Original languageUndefined/Unknown
Pages (from-to)76-83
Number of pages8
JournalHealth Policy
Volume104
Issue number1
DOIs
Publication statusPublished - 2012

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this